Elucidating the exact pharmacological system of action (MOA) of naturally transpiring compounds is usually challenging. Whilst Tarselli et al. (60) made the primary de novo artificial pathway to conolidine and showcased this naturally taking place compound efficiently suppresses responses to both of those chemically induced and inflammation-derived